QLS12010 in Participants With Moderate-to-severe Rheumatoid Arthritis
Clinical trial NCT07377773 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07377773
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-05
- Primary completion
- 2028-03-05
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.